Impact of surgical aortic valve replacement and transcatheter aortic valve implantation on cardiovascular and cerebrovascular controls: A pilot study

Impact of surgical aortic valve replacement and transcatheter aortic valve implantation on cardiovascular and cerebrovascular controls: A pilot study

Surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) are options in severe aortic valve stenosis (AVS). Cardiovascular (CV) and cerebrovascular (CBV) control markers, derived from variability of heart period, systolic arterial pressure, mean cerebral blood velo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Physiological Reports 2024-09, Vol.12 (17), p.e70028-n/a
Hauptverfasser: Bari, Vlasta, Gelpi, Francesca, Cairo, Beatrice, Anguissola, Martina, Acerbi, Elena, Squillace, Mattia, De Maria, Beatrice, Bertoldo, Enrico Giuseppe, Fiolo, Valentina, Callus, Edward, De Vincentiis, Carlo, Bedogni, Francesco, Ranucci, Marco, Porta, Alberto
Format: Artikel
Sprache:eng
Schlagworte:
active standing
Aged
Aged, 80 and over
Aortic valve
Aortic Valve - physiopathology
Aortic Valve - surgery
Aortic valve stenosis
Aortic Valve Stenosis - physiopathology
Aortic Valve Stenosis - surgery
autonomic nervous system
baroreflex
blood flow
Blood pressure
Cardiology
cerebral autoregulation
Cerebrovascular Circulation - physiology
Ejection fraction
Female
Fentanyl
Gender
Heart
heart rate variability
Heart Valve Prosthesis Implantation - methods
Humans
Intensive care
Ischemia
Male
mean arterial blood pressure
Medical research
Medicine, Experimental
Original
Pilot Projects
Regular Manuscript
Remifentanil
Stenosis
Stroke
Transcatheter Aortic Valve Replacement - methods
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) are options in severe aortic valve stenosis (AVS). Cardiovascular (CV) and cerebrovascular (CBV) control markers, derived from variability of heart period, systolic arterial pressure, mean cerebral blood velocity and mean arterial pressure, were acquired in 19 AVS patients (age: 76.8 ± 3.1 yrs, eight males) scheduled for SAVR and in 19 AVS patients (age: 79.9 + 6.5 yrs, 11 males) scheduled for TAVI before (PRE) and after intervention (POST,
ISSN:2051-817X
2051-817X
DOI:10.14814/phy2.70028